EUVIMEDEUVIMED entdecken
BeobachtungsstudieQuerschnittstudie

A cross-sectional observational study of the prevalence and characterization of potential QT-prolonging drug‒drug interactions in oncological outpatients

Akash Agnihotri iD, Biswadeep Das, Sachin Manocha, Manjunath Bidarolli, Bharati Vashisht

Journal of Basic and Clinical Physiology and Pharmacology · 2025

DOI: 10.1515/jbcpp-2024-0104 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Basic and Clinical Physiology and Pharmacology, 2025. Verfasst von Akash Agnihotri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Amrita School of Medicine, Amrita Vishwa Vidyapeetham, Faridabad, Haryana, India. Hauptthemen laut MEDLINE: Neoplasms, Long QT Syndrome, Antineoplastic Agents. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aims to assess the prevalence, characteristics, and risk factors of potential QT-prolonging drug–drug interactions (pQT-DDIs) in cancer patients, including identifying drug combinations contributing to QT prolongation and key predictors.

Methods

In this hospital-based, cross-sectional observational study, all types of cancer patients, irrespective of age or sex, were included over 1 year. pQT-DDIs were identified using four drug interaction checker software tools. Predictors were analyzed using univariate logistic regression.

Results

A total of 1,331 cancer patients were included. The prevalence of pQT-DDIs was 67.6 %. Of these, 606 (45.5 %) had 1–2 pQT-DDIs, 126 (9.5 %) had 3–4, and 78 (5.9 %) had 5–6. Overall, 163 drug combinations were identified as causing QT prolongation; 122 were detected by Drugs.com . Significant predictors included >8 drugs prescribed (OR=6.46; CI=4.87–8.56; p2 anticancer drugs (OR=1.68; CI=1.14–2.46; p=0.008), >6 adjuvant drugs (OR=6.83; CI=5.17–9.03; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsLong QT SyndromeAntineoplastic AgentsHumansMaleCross-Sectional StudiesFemaleDrug InteractionsMiddle AgedPrevalenceAgedRisk FactorsOutpatientsAdultAged, 80 and over

Stichwörter der Autor:innen

QT prolongationanticancer drugsdrug–drug interactionspolypharmacy

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmacology, Amrita School of Medicine, Amrita Vishwa Vidyapeetham, Faridabad, Haryana, India.
  • Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
  • Department of Computer Science, Government College for Girls, Gurugram, Haryana, India.

ORCID-Profile: Akash Agnihotri

Zitieren

APA

Agnihotri, A., Das, B., Manocha, S., Bidarolli, M., & Vashisht, B. (2025). A cross-sectional observational study of the prevalence and characterization of potential QT-prolonging drug‒drug interactions in oncological outpatients. Journal of Basic and Clinical Physiology and Pharmacology. https://doi.org/10.1515/jbcpp-2024-0104

Vancouver

Agnihotri A, Das B, Manocha S, Bidarolli M, Vashisht B. A cross-sectional observational study of the prevalence and characterization of potential QT-prolonging drug‒drug interactions in oncological outpatients. Journal of Basic and Clinical Physiology and Pharmacology. 2025. doi:10.1515/jbcpp-2024-0104

BibTeX
@article{Agnihotri2025,
  author = {Agnihotri, Akash and Das, Biswadeep and Manocha, Sachin and Bidarolli, Manjunath and Vashisht, Bharati},
  title = {A cross-sectional observational study of the prevalence and characterization of potential QT-prolonging drug‒drug interactions in oncological outpatients},
  journal = {Journal of Basic and Clinical Physiology and Pharmacology},
  year = {2025},
  doi = {10.1515/jbcpp-2024-0104}
}
Kostenlos starten →